Compound in broccoli sprouts cleans out diseased lungs: Experimental treatment for COPD in development

April 13, 2011 in Diseases, Conditions, Syndromes

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study published in the April 13 edition of the journal Science Translational Medicine, the Johns Hopkins researchers targeted the Nrf2 pathway using sulforaphane, an ingredient that is present in broccoli in a precursor form, to enhance the Nrf2 pathway in the lung that mediates the uptake of bacteria. Exacerbation of symptoms due to bacterial lung infection is a common problem for many COPD patients. The current study used inflammatory cells from lungs of COPD patients and mice. The experimental therapy is also being studied in a clinical trial.

COPD is major public health problem for both the developed and the developing world. Characterized by chronic bronchitis and emphysema, COPD is the third leading cause of death in the US. COPD affects 24 million Americans and 210 million worldwide. Current treatments are largely symptomatic and supportive, but do not reverse the underlying biological defect in the lung.

For the study, the researchers examined macrophages—white blood cells that kill bacteria—isolated from lungs of COPD patients. The researchers also examined mice exposed to cigarette smoke, which mimicked the immunocompromised conditions in the lungs of COPD patients. The study showed that sulforaphane could increase expression of receptors that improve macrophage phagocytic function. However, further study is needed to determine if a sulforaphane-rich diet could be an effective treatment.

"Our findings suggest that macrophages from the lungs of patients with COPD have a defect in a process called phagocytosis involved in the uptake of bacteria. We discovered that activation of the Nrf2 pathway induced by sulforaphane restored the ability of lung to bind and take up bacteria," said Shyam Biswal, PhD, professor in the Bloomberg School's Department of Environmental Health Sciences and senior author of the study. "The study provides proof of concept that activating the Nrf2 pathway can restore the ability of macrophage to phagocytose, or bind with bacteria, and clear it from the lungs of patients with COPD."

"This research may help explain the long-established link between diet and disease, and raises the potential for new approaches to treatment of this often devastating disease," said Robert Wise, MD, co-author of the study and professor of Medicine in the Johns Hopkins School of Medicine.

More information: "Restoration of Bacterial Phagocytosis in Alveolar Macrophages from COPD Patients by Targeting Nrf2" Christopher J. Harvey, et al., Science Translational Medicine.

Provided by Johns Hopkins University Bloomberg School of Public Health search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Flu vaccine also linked to narcolepsy in adults, study reports

Finnish researchers unveiled new data Thursday to link the Pandemrix flu vaccine to a higher risk of the sleeping disorder narcolepsy in adults.

Diseases, Conditions, Syndromes created 5 minutes ago | popularity not rated yet | comments 0

Second child contracts polio in Pakistan's Waziristan

A second child has contracted polio in a restive Pakistani tribal region near the Afghan border after the Taliban banned vaccinations there nearly a year ago, a UN official said Thursday.

Diseases, Conditions, Syndromes created 25 minutes ago | popularity not rated yet | comments 0

Ferrets, pigs susceptible to H7N9 avian influenza virus

Chinese and U.S. scientists have used virus isolated from a person who died from H7N9 avian influenza infection to determine whether the virus could infect and be transmitted between ferrets. Ferrets are often used as a mammalian ...

Diseases, Conditions, Syndromes created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

WHO says 22 deaths worldwide from coronavirus (Update)

World Health Organization officials said Thursday that their probe into the deadly new coronavirus that has now claimed 22 lives is being delayed because of a dispute over the ownership rights to a sample—a claim disputed ...

Diseases, Conditions, Syndromes created 4 hours ago | popularity not rated yet | comments 0

Researchers suggest boosting body's natural flu killers

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...

Diseases, Conditions, Syndromes created 5 hours ago | popularity not rated yet | comments 0 | with audio podcast


When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Diabetes' genetic underpinnings can vary based on ethnic background, studies say

Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.

Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's

Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...

Study reveals new mechanism for estrogen suppression of liver lipid synthesis

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

Death rates decline for advanced heart failure patients, but outcomes are still not ideal

UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...

MRI-based measurement helps predict vascular disease in the brain

Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...